Clinical Trials Browser

Terminated × Temozolomide × Endocrine × Clear all

NCT03387592 2025-03-10

SENECA

Phase 2 Terminated

Carcinoma, Neuroendocrine

NCT02943733 2022-09-23

Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs

Phase 1 Terminated

Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT03930771 2022-08-09

TMZ-Cap

Phase 2 Terminated

1 enrolled 8 charts

Pituitary Neoplasms